Phase I study of docetaxel and epirubicin in advanced breast cancer

被引：0
|
作者：
Panagos, G [1 ]
Mavroudis, D [1 ]
Potamianou, A [1 ]
Malamos, N [1 ]
Kourousis, C [1 ]
Kakolyris, S [1 ]
Souglakos, J [1 ]
Sarra, E [1 ]
Giannakakis, T [1 ]
Georgoulias, V [1 ]
机构：
[1] Univ Gen Hosp, Dept Med Oncol, Greek Cooperat Grp Breast Canc, Heraklion 71110, Crete, Greece
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
97P
引用
收藏
页码：21 / 21
页数：1
相关论文
共 50 条
  • [1] Docetaxel and epirubicin in advanced breast cancer
    Sessa, C
    Pagani, O
    [J]. ONCOLOGIST, 2001, 6 : 13 - 16
  • [2] Epirubicin and docetaxel as neoadjuvant treatment of locally advanced breast cancer: a phase II study
    Lombardi, Davide
    Scalone, Simona
    Crivellari, Diana
    Magri, Maria Donatella
    La Mura, Nicoletta
    Miolo, GianMaria
    Murrone, Antonio
    Perin, Tiziana
    Coran, Francesco
    Candiani, Ezio
    Massarut, Samuele
    Veronesi, Andrea
    [J]. TUMORI JOURNAL, 2010, 96 (02): : 229 - 233
  • [3] Epirubicin and docetaxel as neoadjuvant treatment of locally advanced breast cancer: a phase II study
    Lombardi, D.
    Scalone, S.
    Crivellari, D.
    La Mura, N.
    Miolo, G.
    Murrone, A.
    Perin, T.
    Coran, F.
    Candiani, E.
    Massarut, S.
    Veronesi, A.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S229 - S229
  • [4] Phase I study of docetaxel epirubicin and cyclophosphamide (TEC) in patients with advanced cancer (AC)
    Ackland, S
    Rischin, D
    Beith, J
    Gupta, S
    Wyatt, S
    Davison, J
    Johnson, C
    Teriana, N
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S292 - S292
  • [5] Epirubicin/docetaxel regimen in progressive breast cancer -: a phase II study
    Salminen, E
    Korpela, J
    Varpula, M
    Asola, R
    Varjo, P
    Pyrhönen, S
    Mali, P
    Hinkka, S
    Ekholm, E
    [J]. ANTI-CANCER DRUGS, 2002, 13 (09) : 925 - 929
  • [6] Front-line treatment of advanced breast cancer with docetaxel and epirubicin: A multicenter phase II study
    Mavroudis, D
    Alexopoulos, A
    Ziras, N
    Malamos, N
    Kouroussis, C
    Kakolyris, S
    Agelaki, S
    Kalbakis, K
    Tsavaris, N
    Potamianou, A
    Rigatos, G
    Georgoulias, V
    [J]. ANNALS OF ONCOLOGY, 2000, 11 (10) : 1249 - 1254
  • [7] Phase II study of neoadjuvant therapy with epirubicin and docetaxel for women with locally advanced breast cancer.
    Holter, JL
    Tfayli, A
    Venkattapa, S
    Bova, A
    Howard, O
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 98S - 98S
  • [8] Dose escalation study of epirubicin and docetaxel in patients with advanced or recurrent breast cancer
    Ichinose, Ichiro
    Hamada, Yuzo
    Mitsuyama, Shoshu
    Ishikawa, Emi
    Ikeda, Tadashi
    Kobayashi, Sunao
    Horikoshi, Noboru
    Tamura, Kazuo
    [J]. CHEMOTHERAPY, 2008, 54 (05): : 379 - 385
  • [9] Phase I study of docetaxel and cyclophosphamide in patients with advanced or recurrent breast cancer
    Tadao Shimizu
    Kohji Enomoto
    Shunsuke Haga
    Mamoru Fukuda
    Yuichi lino
    Tadashi lkeda
    Tetsuo Taguchi
    [J]. Breast Cancer, 2003, 10 (2) : 140 - 148
  • [10] Phase I-study of dose escalated epirubicin with gemcitabine in advanced breast cancer
    Luftner, D
    Grunewald, R
    Flath, B
    Akrivakis, C
    Blatter, J
    Mergenthaler, HG
    Possinger, K
    [J]. 10TH MEDITERRANEAN CONGRESS OF CHEMOTHERAPY, 1996, : 537 - 541
12345